Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 10, 571-576, September 1, 1950]
© 1950 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidsohn, I.
Right arrow Articles by Stern, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidsohn, I.
Right arrow Articles by Stern, K.

Further Studies on Natural Antisheep Agglutinins in Mice of Inbred Strains* {dagger},

Israel Davidsohn, M.D. and Kurt Stern, M.D.

(From the Department of Pathology, Chicago Medical School, and the Mount Sinai Medical Research Foundation, Chicago, Illinois)

1. Natural antisheep agglutinins have been studied thus far in strains C57 black, C3H, dba, Marsh-albino, B alb C, Akm, C57 brown, and I.
2. The antisheep agglutinin in mice is not of the Forssman type.
3. Antigen of Forssman type was found in normal and neoplastic tissues of C3H, dba, and C57 black mice, independent of strain. The antigen was not present in the erythrocytes.
4. No relationship was noted between presence and titer of natural antisheep agglutinins and the incidence of spontaneous tumors in the strains studied.
5. The incidence and titer of antisheep agglutinin in C57 black mice showed a progressive rise from the fifth to the twelfth weeks of life.

* Presented at the Forty-first Annual Meeting of the American Association for Cancer Research, Atlantic City, New Jersey, April 18, 1950.

{dagger} This investigation was supported (in part) by a research grant from the National Cancer Institute, National Institute of Health, Public Health Service.

Received 5/ 6/50.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1950 by the American Association for Cancer Research.